amifostine anhydrous has been researched along with Ear Diseases in 3 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Ear Diseases: Pathological processes of the ear, the hearing, and the equilibrium system of the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duval, M | 1 |
| Daniel, SJ | 1 |
| Fisher, MJ | 1 |
| Lange, BJ | 1 |
| Needle, MN | 1 |
| Janss, AJ | 1 |
| Shu, HK | 1 |
| Adamson, PC | 1 |
| Phillips, PC | 1 |
| Treskes, M | 1 |
| van der Vijgh, WJ | 1 |
2 reviews available for amifostine anhydrous and Ear Diseases
| Article | Year |
|---|---|
Meta-analysis of the efficacy of amifostine in the prevention of cisplatin ototoxicity.
Topics: Amifostine; Antineoplastic Agents; Cisplatin; Ear Diseases; Humans; Neoplasms; Radiation-Protective | 2012 |
WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.
Topics: Amifostine; Animals; Bone Marrow Diseases; Carboplatin; Cisplatin; Ear Diseases; Gastrointestinal Di | 1993 |
1 trial available for amifostine anhydrous and Ear Diseases
| Article | Year |
|---|---|
Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy.
Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Drug | 2004 |